ScoreWhy is Hubei Hongyuan Pharmaceutical Technology Co., Ltd. ?
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of -1.45% and Operating profit at -123.24% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 10.19% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of -1.45% and Operating profit at -123.24% over the last 5 years
3
The company has declared Negative results for the last 11 consecutive quarters
- NET PROFIT(HY) At CNY -7.93 MM has Grown at -198.67%
- OPERATING CASH FLOW(Y) Lowest at CNY -214.74 MM
- ROCE(HY) Lowest at 0.33%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Hubei Hongyuan Pharmaceutical Technology Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Hubei Hongyuan Pharmaceutical Technology Co., Ltd.
-100.0%
0.98
55.06%
China Shanghai Composite
16.01%
1.03
14.98%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-1.45%
EBIT Growth (5y)
-123.24%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.18
Sales to Capital Employed (avg)
0.37
Tax Ratio
12.27%
Dividend Payout Ratio
23.24%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
16.26%
ROE (avg)
10.19%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
129
Industry P/E
Price to Book Value
0.15
EV to EBIT
18.96
EV to EBITDA
-1.86
EV to Capital Employed
-0.10
EV to Sales
-0.18
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
0.12%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
NET PROFIT(Q)
At CNY 3.83 MM has Grown at 869.33%
INTEREST COVERAGE RATIO(Q)
The company hardly has any interest cost
RAW MATERIAL COST(Y)
Fallen by -44.08% (YoY
-17What is not working for the Company
NET PROFIT(HY)
At CNY -7.93 MM has Grown at -198.67%
OPERATING CASH FLOW(Y)
Lowest at CNY -214.74 MM
ROCE(HY)
Lowest at 0.33%
DEBT-EQUITY RATIO
(HY)
Highest at -10.03 %
OPERATING PROFIT(Q)
Lowest at CNY 5 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 1.15 %
Here's what is working for Hubei Hongyuan Pharmaceutical Technology Co., Ltd.
Net Profit
At CNY 3.83 MM has Grown at 869.33%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Raw Material Cost
Fallen by -44.08% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Hubei Hongyuan Pharmaceutical Technology Co., Ltd.
Operating Cash Flow
Lowest at CNY -214.74 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Debt-Equity Ratio
Highest at -10.03 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Operating Profit
Lowest at CNY 5 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at 1.15 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
